Keros Therapeutics, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last report2 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
+1.38%
vs ±25.5% implied · ×0.05
shaded = implied · ▲▼ = realized
Keros Therapeutics, Inc.
11.04
No thesis.
Fund move
Fund move
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | BlackRockBlackRockindex-like | $29.9M | 15.05% | +15.86% | |
| 2 | Nantahala Capital ManagementNantahala | $15.1M | 7.59% | +3.68% | |
| 3 | AQR Capital ManagementAQR | $10.4M | 5.21% | +138.06% | |
| 4 | Vanguard Capital ManagementVanguardindex-like | $8.9M | 4.49% | +0.26% | |
| 5 | Orbimed AdvisorsOrbimed | $8.1M | 4.09% | 0.00% | |
| 6 | Federated InvestorsFederated Investors | $7.5M | 3.77% | +1.62% | |
| 7 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $7.0M | 3.51% | −4.31% | |
| 8 | Mackenzie FinancialMackenzie Financial | $6.7M | 3.38% | +312.23% | |
| 9 | Madison Avenue PartnersMadison Avenue Partners | $6.7M | 3.37% | 0.00% | |
| 10 | Qube Research & TechnologiesQube Research & Technologies | $6.5M | 3.28% | −16.01% | |
| 11 | Jacobs Levy Equity ManagementJacobs Levy Equity | $6.5M | 3.26% | −14.25% | |
| 12 | State StreetState Streetindex-like | $5.8M | 2.91% | −3.66% | |
| 13 | Geode Capital ManagementGeodeindex-like | $5.5M | 2.75% | −25.04% | |
| 14 | Dimensional Fund AdvisorsDimensional | $4.9M | 2.48% | +43.31% | |
| 15 | Citadel AdvisorsCitadel | $4.4M | 2.21% | −25.87% | |
| 16 | Renaissance TechnologiesRenaissance Technologies | $3.8M | 1.93% | −20.82% | |
| 17 | D. E. ShawD. E. Shaw | $2.9M | 1.44% | −47.52% | |
| 18 | Bridgeway Capital ManagementBridgeway | $2.8M | 1.43% | +35.89% | |
| 19 | NuveenNuveenindex-like | $2.7M | 1.33% | −5.46% | |
| 20 | ADAR1 Capital ManagementADAR1 | $2.6M | 1.33% | +153.62% | |
| 21 | Two Sigma InvestmentsTwo Sigma | $2.6M | 1.33% | −32.21% | |
| 22 | Arrowstreet Capital, Limited PartnershipArrowstreet Capital, Limited Partnership | $2.5M | 1.26% | −60.50% | |
| 23 | Millennium ManagementMillennium | $2.0M | 1.00% | +72.96% | |
| 24 | Goldman Sachs GroupGoldman Sachs | $1.9M | 0.96% | −20.77% | |
| 25 | Charles Schwab Investment ManagementCharles Schwabindex-like | $1.7M | 0.85% | −11.80% |
131 managers report $198.7M of Keros Therapeutics on form 13F for the quarter ended Jun 30 '26. 25 of them hold 80% of it; BlackRock is largest at 15.05%.
Linked news
NewsNo implied move.
No implied move.
Expected move
No implied move.